Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

16.75EUR
23 Feb 2018
Change (% chg)

€-0.12 (-0.71%)
Prev Close
€16.87
Open
€16.77
Day's High
€16.93
Day's Low
€16.65
Volume
23,759
Avg. Vol
80,402
52-wk High
€30.20
52-wk Low
€14.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 1.79 -1.420
Jun '17 1.79 -0.947
FY 2016 Dec '16 1.74 -1.433
Jun '16 2.40 -1.310
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 6 6.33 17.00 0.00 18.57
Earnings (per share)
Year Ending Dec-18 6 -1.84 -1.18 -2.65 -2.62
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 0.86 0.90 0.89
Price to Sales (TTM) 80.61 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions -- 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -8.67 78.63 5.59
Sales - 5 Yr. Growth Rate 35.25 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 81.34 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) -- 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -572.68 10.86
Operating Margin (TTM) -736.87 -717.10 4.64
Operating Margin - 5 Yr. Avg. -331.17 -594.00 6.26
Pre-Tax Margin (TTM) -727.19 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -337.58 -597.35 6.60
Net Profit Margin (TTM) -727.87 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -337.31 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 22,602,130 855,673,508
Net Income/Employee (TTM) -301,682 2,968,748 100,656,226
Receivable Turnover (TTM) -- 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) -- 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.05 10.98
Return on Assets - 5 Yr. Avg. -38.25 -0.57 12.37
Return on Investment (TTM) -- 1.66 14.43
Return on Investment - 5 Yr. Avg. -46.07 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -51.29 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 37 53
13 Week -7.07 -10.79 74 62
26 Week -12.20 -15.88 75 77
52 Week 35.52 13.27 99 50
YTD 76.06 59.71 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 47.37%
# of Holders: 26
Total Shares Held: 8,495,414
3 Mo. Net Change: 4,031,777
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 10
# Reduced Positions: 3
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.